{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:32:57Z","timestamp":1791973977814,"version":"4.4.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oculopharyngeal muscular dystrophy (OPMD) is a late-onset muscular dystrophy characterised by slowly progressive ptosis, dysphagia, and proximal limb muscle weakness. A common cause of OPMD is the short expansion of a GCG or GCA trinucleotide repeat in <jats:italic>PABPN1<\/jats:italic> gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 78-year-old woman presented with ptosis and gradually progressive dysphagia. Her son had the same symptoms. A physical examination and muscle imaging (MRI and ultrasound) showed impairment of the tongue, proximal muscles of the upper limbs, and flexor muscles of the lower limbs. Needle-electromyography (EMG) of bulbar and facial muscles revealed a myopathic pattern. Based on the characteristic muscle involvement pattern and needle-EMG findings, we suspected that the patient had OPMD. Gene analysis revealed <jats:italic>PABPN1<\/jats:italic> c.35G\u2009&gt;\u2009C point mutation, which mimicked the effect of a common causative repeat expansion mutation of OPMD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We herein describe the first reported Japanese case of OPMD with <jats:italic>PABPN1<\/jats:italic> point mutation, suggesting that this mutation is causative in Asians as well as in Europeans, in whom it was originally reported.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02300-x","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T11:03:04Z","timestamp":1625482984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G\u2009&gt;\u2009C; p.Gly12Ala point mutation"],"prefix":"10.1186","volume":"21","author":[{"given":"Yo-suke","family":"Nishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ichi","family":"Noto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Kitaoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijirou","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narihiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"issue":"3","key":"2300_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1212\/WNL.46.3.773","volume":"46","author":"E Uyama","year":"1996","unstructured":"Uyama E, Nohira O, Chateau D, Tokunaga M, Uchino M, Okabe T, Ando M, Tome FM. Oculopharyngeal muscular dystrophy in two unrelated Japanese families. Neurology. 1996;46(3):773\u20138.","journal-title":"Neurology"},{"issue":"3","key":"2300_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0960-8966(99)00104-2","volume":"10","author":"T Nagashima","year":"2000","unstructured":"Nagashima T, Kato H, Kase M, Maguchi S, Mizutani Y, Matsuda K, Chuma T, Mano Y, Goto Y, Minami N, et al. Oculopharyngeal muscular dystrophy in a Japanese family with a short GCG expansion (GCG)(11) in PABP2 gene. Neuromuscul Disord. 2000;10(3):173\u20137.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"2300_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nmd.2004.10.016","volume":"15","author":"KJ Goh","year":"2005","unstructured":"Goh KJ, Wong KT, Nishino I, Minami N, Nonaka I. Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman. Neuromuscul Disord. 2005;15(3):262\u20134.","journal-title":"Neuromuscul Disord"},{"issue":"1\u20132","key":"2300_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2008.11.001","volume":"278","author":"HC Kuo","year":"2009","unstructured":"Kuo HC, Chen CM, Lee-Chen GJ, Hu FJ, Chu CC, Liou CW, Huang CC. Study of a Taiwanese family with oculopharyngeal muscular dystrophy. J Neurol Sci. 2009;278(1\u20132):21\u20134.","journal-title":"J Neurol Sci"},{"issue":"4","key":"2300_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s12017-014-8327-5","volume":"16","author":"J Shan","year":"2014","unstructured":"Shan J, Chen B, Lin P, Li D, Luo Y, Ji K, Zheng J, Yuan Y, Yan C. Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population. Neuromolecular Med. 2014;16(4):782\u20136.","journal-title":"Neuromolecular Med"},{"issue":"7","key":"2300_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00415-011-5937-9","volume":"258","author":"A Fischmann","year":"2011","unstructured":"Fischmann A, Gloor M, Fasler S, Haas T, Rodoni Wetzel R, Bieri O, Wetzel S, Heinimann K, Scheffler K, Fischer D. Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy. J Neurol. 2011;258(7):1333\u201340.","journal-title":"J Neurol"},{"issue":"5","key":"2300_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/jnnp-2018-319578","volume":"90","author":"A Alonso-Jimenez","year":"2019","unstructured":"Alonso-Jimenez A, Kroon R, Alejaldre-Monforte A, Nu\u00f1ez-Peralta C, Horlings CGC, van Engelen BGM, Oliv\u00e9 M, Gonz\u00e1lez L, Verges-Gil E, Paradas C, et al. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy. J Neurol Neurosurg Psychiatry. 2019;90(5):576\u201385.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2300_CR8","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1136\/jmg.2005.037598","volume":"43","author":"DO Robinson","year":"2005","unstructured":"Robinson DO. Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation. J Med Genet. 2005;43(5):e23\u2013e23.","journal-title":"J Med Genet"},{"issue":"11","key":"2300_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.nmd.2011.06.003","volume":"21","author":"DO Robinson","year":"2011","unstructured":"Robinson DO, Hilton-Jones D, Mansfield D, Hildebrand GD, Marks S, Mechan D, Ramsay J. Two cases of oculopharyngeal muscular dystrophy (OPMD) with the rare PABPN1 c.35G>C; p.Gly12Ala point mutation. Neuromuscul Disord. 2011;21(11):809\u201311.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"2300_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ng0298-164","volume":"18","author":"B Brais","year":"1998","unstructured":"Brais B, Bouchard JP, Xie YG, Rochefort DL, Chr\u00e9tien N, Tom\u00e9 FM, Lafreni\u00e8re RG, Rommens JM, Uyama E, Nohira O, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 1998;18(2):164\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"2300_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1212\/WNL.0000000000003554","volume":"88","author":"P Richard","year":"2017","unstructured":"Richard P, Trollet C, Stojkovic T, de Becdelievre A, Perie S, Pouget J, Eymard B. Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy. Neurology. 2017;88(4):359\u201365.","journal-title":"Neurology"},{"issue":"1","key":"2300_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11910-009-0012-y","volume":"9","author":"B Brais","year":"2009","unstructured":"Brais B. Oculopharyngeal muscular dystrophy: a polyalanine myopathy. Curr Neurol Neurosci Rep. 2009;9(1):76\u201382.","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02300-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T11:03:11Z","timestamp":1625482991000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02300-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2300"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02300-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. The patient was evaluated at Kyoto Prefectural University of Medicine hospital under a protocol approved by the local ethics committee of Kyoto Prefectural University of Medicine. Written informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"265"}}